Brought to you by:
FFRCT diagnosis of coronary ischemia with ischemia-targeted coronary revascularization more than halves five-year risk of cardiac death and MI following CEA
Preoperative diagnosis of lesion-specific ischemia using coronary computed tomography (CT)-derived fractional flow reserve (FFRCT) and ischemia-targeted coronary revascularization after carotid endarterectomy (CEA) can reduce the five-year risk of cardiac death and myocardial infarction (MI) by more than 50% and improve…
SCOREPAD seeks to address ‘alarmingly high’ mortality in CLTI patients with underlying coronary disease
A new research letter underscores the need to improve long-term survival following lower extremity revascularization for chronic limb-threatening ischemia (CLTI), setting out a randomized controlled trial to examine the impact of coronary artery ischemia testing in these patients. The letter,…
CSI announces development of IVL technology for the treatment of PAD
Cardiovascular Systems (CSI) recently announced that it has made significant progress towards the commercialization of its intravascular lithotripsy (IVL) system for the treatment of calcific peripheral arterial disease (PAD). A company press release notes that feasibility testing of a proprietary…